Published Date：Feb.2021
Industry：Pharma & Healthcare
Pages：108 Table Number：123
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Acoustic Neuroma Treatment market in this environment. In terms of revenue, this research report indicated that the global Acoustic Neuroma Treatment market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Acoustic Neuroma Treatment industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The GE Healthcare aims at producing XX K Units Acoustic Neuroma Treatment in 2020, with XX % production to take place in global market, Siemens Healthcare accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Acoustic Neuroma Treatment Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Acoustic Neuroma Treatment Market? GE Healthcare Siemens Healthcare Philips Healthcare Shimadzu Corporation Toshiba Medical Systems Corporation F. Hoffmann-La Roche Ag Merck & Co., Inc. Novartis AG Pfizer Inc. Electa ... Major Type of Acoustic Neuroma Treatment Covered in XYZResearch report: Unilateral acoustic neurinoma Bilateral acoustic neurinoma Application Segments Covered in XYZResearch Market Hospitals Diagnostic centers Academic and Research institutes For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Acoustic Neuroma Treatment Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Unilateral acoustic neurinoma -Product Introduction and Major Manufacturers 1.1.2 Bilateral acoustic neurinoma -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Acoustic Neuroma Treatment Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027) 2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027) 3 Regional Market Analysis 3.1 China Acoustic Neuroma Treatment Market 3.1.1 Top Companies leading Acoustic Neuroma Treatment Development in China (2016-2021) 3.1.2 Sales Value of Major Company in China Market (2016-2021) 3.1.3 China Acoustic Neuroma Treatment Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2026-2027) 3.2 EU Acoustic Neuroma Treatment Market 3.2.1 Top Companies leading Acoustic Neuroma Treatment Development in EU (2016-2021) 3.2.2 Sales Value of Major Company in EU Market (2016-2021) 3.2.3 EU Acoustic Neuroma Treatment Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2026-2027) 3.3 USA Acoustic Neuroma Treatment Market 3.3.1 Top Companies leading Acoustic Neuroma Treatment Development in USA (2016-2021) 3.3.2 Sales Value of Major Company in USA Market (2016-2021) 3.3.3 USA Acoustic Neuroma Treatment Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2026-2027) 3.4 Japan Acoustic Neuroma Treatment Market 3.4.1 Top Companies leading Acoustic Neuroma Treatment Development in Japan (2016-2021) 3.4.2 Sales Value of Major Company in Japan Market (2016-2021) 3.4.3 Japan Acoustic Neuroma Treatment Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2026-2027) 3.5 India Acoustic Neuroma Treatment Market 3.5.1 Top Companies leading Acoustic Neuroma Treatment Development in India (2016-2021) 3.5.2 Sales Value of Major Company in India Market (2016-2021) 3.5.3 India Acoustic Neuroma Treatment Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2026-2027) 3.6 Southeast Asia Acoustic Neuroma Treatment Market 3.6.1 Top Companies leading Acoustic Neuroma Treatment Development in Southeast Asia (2016-2021) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021) 3.6.3 Southeast Asia Acoustic Neuroma Treatment Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2026-2027) 3.7 South America Acoustic Neuroma Treatment Market 3.7.1 Top Companies leading Acoustic Neuroma Treatment Development in South America (2016-2021) 3.7.2 Sales Value of Major Company in South America Market (2016-2021) 3.7.3 South America Acoustic Neuroma Treatment Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2026-2027) 4 Value Chain (Impact of COVID-19) 4.1 Acoustic Neuroma Treatment Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Acoustic Neuroma Treatment Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2027) 5.1 Global Acoustic Neuroma Treatment Sales and Growth Rate (2021-2027) 5.2 Global Acoustic Neuroma Treatment Sales Value and Growth Rate (2021-2027) 6 Acoustic Neuroma Treatment Competitive Analysis 6.1 GE Healthcare 6.1.1 GE Healthcare Company Profiles 6.1.2 GE Healthcare Product Introduction 6.1.3 GE Healthcare Acoustic Neuroma Treatment Production, Revenue (2016-2021) 6.1.4 SWOT Analysis 6.2 Siemens Healthcare 6.2.1 Siemens Healthcare Company Profiles 6.2.2 Siemens Healthcare Product Introduction 6.2.3 Siemens Healthcare Acoustic Neuroma Treatment Production, Revenue (2016-2021) 6.2.4 SWOT Analysis 6.3 Philips Healthcare 6.3.1 Philips Healthcare Company Profiles 6.3.2 Philips Healthcare Product Introduction 6.3.3 Philips Healthcare Acoustic Neuroma Treatment Production, Revenue (2016-2021) 6.3.4 SWOT Analysis 6.4 Shimadzu Corporation 6.4.1 Shimadzu Corporation Company Profiles 6.4.2 Shimadzu Corporation Product Introduction 6.4.3 Shimadzu Corporation Acoustic Neuroma Treatment Production, Revenue (2016-2021) 6.4.4 SWOT Analysis 6.5 Toshiba Medical Systems Corporation 6.5.1 Toshiba Medical Systems Corporation Company Profiles 6.5.2 Toshiba Medical Systems Corporation Product Introduction 6.5.3 Toshiba Medical Systems Corporation Acoustic Neuroma Treatment Production, Revenue (2016-2021) 6.5.4 SWOT Analysis 6.6 F. Hoffmann-La Roche Ag 6.6.1 F. Hoffmann-La Roche Ag Company Profiles 6.6.2 F. Hoffmann-La Roche Ag Product Introduction 6.6.3 F. Hoffmann-La Roche Ag Acoustic Neuroma Treatment Production, Revenue (2016-2021) 6.6.4 SWOT Analysis 6.7 Merck & Co., Inc. 6.7.1 Merck & Co., Inc. Company Profiles 6.7.2 Merck & Co., Inc. Product Introduction 6.7.3 Merck & Co., Inc. Acoustic Neuroma Treatment Production, Revenue (2016-2021) 6.7.4 SWOT Analysis 6.8 Novartis AG 6.8.1 Novartis AG Company Profiles 6.8.2 Novartis AG Product Introduction 6.8.3 Novartis AG Acoustic Neuroma Treatment Production, Revenue (2016-2021) 6.8.4 SWOT Analysis 6.9 Pfizer Inc. 6.9.1 Pfizer Inc. Company Profiles 6.9.2 Pfizer Inc. Product Introduction 6.9.3 Pfizer Inc. Acoustic Neuroma Treatment Production, Revenue (2016-2021) 6.9.4 SWOT Analysis 6.10 Electa 6.10.1 Electa Company Profiles 6.10.2 Electa Product Introduction 6.10.3 Electa Acoustic Neuroma Treatment Production, Revenue (2016-2021) 6.10.4 SWOT Analysis 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2016-2021) Figure Global Acoustic Neuroma Treatment Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2027) Table CAGR in Terms of Production of Each Type (2026-2027) Table CAGR in Terms of Production of Each Application (2026-2027) Table Global Acoustic Neuroma Treatment Sales (K Unit) by Type (2026-2027) Figure Global Acoustic Neuroma Treatment Sales (K Unit) and Growth Rate (2026-2027) Figure Global Acoustic Neuroma Treatment Sales Market Share (%) by Type (2019 -2020) Table Global Acoustic Neuroma Treatment Sales Value (Million USD) by Type (2026-2027) Figure Global Acoustic Neuroma Treatment Sales Value (Million USD) and Growth Rate (2026-2027) Figure Global Acoustic Neuroma Treatment Sales Value Market Share (%) by Type (2019-2020) Table Global Acoustic Neuroma Treatment Sales (K Unit) by Application (2026-2027) Table China Acoustic Neuroma Treatment Sales (K Unit) of Major Company (2016-2021) Table China Acoustic Neuroma Treatment Sales Market Share of Major Company (2016-2021) Table China Acoustic Neuroma Treatment Sales Value (Million USD) of Major Company (2016-2021) Figure China Acoustic Neuroma Treatment Sales Value (Million USD) and Growth Rate (2016-2021) Table China Acoustic Neuroma Treatment Sales Value Share of Major Company (2016-2021) Table China Acoustic Neuroma Treatment Price (USD/Unit), by Type (2019-2020) Table China Acoustic Neuroma Treatment Sales (Unit) by Type (2026-2027) Figure China Acoustic Neuroma Treatment Sales (Unit) by Type (2026-2027) Table EU Acoustic Neuroma Treatment Sales (K Unit) of Major Company (2016-2021) Table EU Acoustic Neuroma Treatment Sales Market Share of Major Company (2016-2021) Table EU Acoustic Neuroma Treatment Sales Value (Million USD) of Major Company (2016-2021) Figure EU Acoustic Neuroma Treatment Sales Value (Million USD) and Growth Rate (2016-2021) Table EU Acoustic Neuroma Treatment Sales Value Share of Major Company (2016-2021) Table EU Acoustic Neuroma Treatment Price (USD/Unit), by Type (2019-2020) Table EU Acoustic Neuroma Treatment Sales (Unit) by Type (2026-2027) Figure EU Acoustic Neuroma Treatment Sales (Unit) by Type (2026-2027) Table USA Acoustic Neuroma Treatment Sales (K Unit) of Major Company (2016-2021) Table USA Acoustic Neuroma Treatment Sales Market Share of Major Company (2016-2021) Table USA Acoustic Neuroma Treatment Sales Value (Million USD) of Major Company (2016-2021) Figure USA Acoustic Neuroma Treatment Sales Value (Million USD) and Growth Rate (2016-2021) Table USA Acoustic Neuroma Treatment Sales Value Share of Major Company (2016-2021) Table USA Acoustic Neuroma Treatment Price (USD/Unit), by Type (2019-2020) Table USA Acoustic Neuroma Treatment Sales (Unit) by Type (2026-2027) Figure USA Acoustic Neuroma Treatment Sales (Unit) by Type (2026-2027) Table Japan Acoustic Neuroma Treatment Sales (K Unit) of Major Company (2016-2021) Table Japan Acoustic Neuroma Treatment Sales Market Share of Major Company (2016-2021) Table Japan Acoustic Neuroma Treatment Sales Value (Million USD) of Major Company (2016-2021) Figure Japan Acoustic Neuroma Treatment Sales Value (Million USD) and Growth Rate (2016-2021) Table Japan Acoustic Neuroma Treatment Sales Value Share of Major Company (2016-2021) Table Japan Acoustic Neuroma Treatment Price (USD/Unit), by Type (2019-2020) Table Japan Acoustic Neuroma Treatment Sales (Unit) by Type (2026-2027) Figure Japan Acoustic Neuroma Treatment Sales (Unit) by Type (2026-2027) Table India Acoustic Neuroma Treatment Sales (K Unit) of Major Company (2016-2021) Table India Acoustic Neuroma Treatment Sales Market Share of Major Company (2016-2021) Table India Acoustic Neuroma Treatment Sales Value (Million USD) of Major Company (2016-2021) Figure India Acoustic Neuroma Treatment Sales Value (Million USD) and Growth Rate (2016-2021) Table India Acoustic Neuroma Treatment Sales Value Share of Major Company (2016-2021) Table India Acoustic Neuroma Treatment Price (USD/Unit), by Type (2019-2020) Table India Acoustic Neuroma Treatment Sales (Unit) by Type (2026-2027) Figure India Acoustic Neuroma Treatment Sales (Unit) by Type (2026-2027) Table Southeast Asia Acoustic Neuroma Treatment Sales (K Unit) of Major Company (2016-2021) Table Southeast Asia Acoustic Neuroma Treatment Sales Market Share of Major Company (2016-2021) Table Southeast Asia Acoustic Neuroma Treatment Sales Value (Million USD) of Major Company (2016-2021) Figure Southeast Asia Acoustic Neuroma Treatment Sales Value (Million USD) and Growth Rate (2016-2021) Table Southeast Asia Acoustic Neuroma Treatment Sales Value Share of Major Company (2016-2021) Table Southeast Asia Acoustic Neuroma Treatment Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Acoustic Neuroma Treatment Sales (Unit) by Type (2026-2027) Figure Southeast Asia Acoustic Neuroma Treatment Sales (Unit) by Type (2026-2027) Table South America Acoustic Neuroma Treatment Sales (K Unit) of Major Company (2016-2021) Table South America Acoustic Neuroma Treatment Sales Market Share of Major Company (2016-2021) Table South America Acoustic Neuroma Treatment Sales Value (Million USD) of Major Company (2016-2021) Figure South America Acoustic Neuroma Treatment Sales Value (Million USD) and Growth Rate (2016-2021) Table South America Acoustic Neuroma Treatment Sales Value Share of Major Company (2016-2021) Table South America Acoustic Neuroma Treatment Price (USD/Unit), by Type (2019-2020) Table South America Acoustic Neuroma Treatment Sales (Unit) by Type (2026-2027) Figure South America Acoustic Neuroma Treatment Sales (Unit) by Type (2026-2027) Figure Value Chain Structure of Acoustic Neuroma Treatment Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Acoustic Neuroma Treatment Figure Cost Structure of Acoustic Neuroma Treatment in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2027) Table Regional Market Sales Share (2021-2027) Figure Global Acoustic Neuroma Treatment Sales (Unit), Growth Rate & Market Share (2021-2027) Table Regional Market Sales Value (Million USD) (2021-2027) Table Regional Market Sales Value Share (2021-2027) Figure Global Acoustic Neuroma Treatment Sales Value (Million USD), Growth Rate & Market Share (2021-2027) Table GE Healthcare Profiles Table GE Healthcare Acoustic Neuroma Treatment Product Introduction Table GE Healthcare Acoustic Neuroma Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure GE Healthcare SWOT Analysis Table Siemens Healthcare Profiles Table Siemens Healthcare Acoustic Neuroma Treatment Product Introduction Table Siemens Healthcare Acoustic Neuroma Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Siemens Healthcare SWOT Analysis Table Philips Healthcare Profiles Table Philips Healthcare Acoustic Neuroma Treatment Product Introduction Table Philips Healthcare Acoustic Neuroma Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Philips Healthcare SWOT Analysis Table Shimadzu Corporation Profiles Table Shimadzu Corporation Acoustic Neuroma Treatment Product Introduction Table Shimadzu Corporation Acoustic Neuroma Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Shimadzu Corporation SWOT Analysis Table Toshiba Medical Systems Corporation Profiles Table Toshiba Medical Systems Corporation Acoustic Neuroma Treatment Product Introduction Table Toshiba Medical Systems Corporation Acoustic Neuroma Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Toshiba Medical Systems Corporation SWOT Analysis Table F. Hoffmann-La Roche Ag Profiles Table F. Hoffmann-La Roche Ag Acoustic Neuroma Treatment Product Introduction Table F. Hoffmann-La Roche Ag Acoustic Neuroma Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure F. Hoffmann-La Roche Ag SWOT Analysis Table Merck & Co., Inc. Profiles Table Merck & Co., Inc. Acoustic Neuroma Treatment Product Introduction Table Merck & Co., Inc. Acoustic Neuroma Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Merck & Co., Inc. SWOT Analysis Table Novartis AG Profiles Table Novartis AG Acoustic Neuroma Treatment Product Introduction Table Novartis AG Acoustic Neuroma Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Novartis AG SWOT Analysis Table Pfizer Inc. Profiles Table Pfizer Inc. Acoustic Neuroma Treatment Product Introduction Table Pfizer Inc. Acoustic Neuroma Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Pfizer Inc. SWOT Analysis Table Electa Profiles Table Electa Acoustic Neuroma Treatment Product Introduction Table Electa Acoustic Neuroma Treatment Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021)
